Wedbush Forecasts Biogen’s Q3 Earnings (NASDAQ:BIIB)

Biogen Inc. (NASDAQ:BIIB – Free Report) – Investment analysts at Wedbush decreased their Q3 2025 EPS estimates for Biogen in a report issued on Thursday, July 31st. Wedbush analyst L. Chico now expects that the biotechnology company will earn $3.76 per share for the quarter, down from their prior forecast of $3.81. Wedbush has a […]

Leave a Reply

Your email address will not be published.

Previous post Equities Analysts Set Expectations for argenex Q3 Earnings
Next post Q3 EPS Estimates for CP Decreased by National Bank Financial